Zhejiang Hisun Pharmaceutical Co., Ltd.
SHH: 600267.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Weihong Xiao
- Employees
- 8,062
- Headquarters
- Taizhou, China
- IPO year
- 2000
- Market cap
- CN¥13.8B
- Website
- https://www.hisunpharm.com
Loading 600267…
Loading profile data…Frequently asked questions about 600267
What does Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS) do?
Zhejiang Hisun Pharmaceutical Co., Ltd. manufactures and supplies pharmaceutical products in China. It provides active pharmaceutical ingredients and finished dosage form products. The company offers products in the areas of anti-tumor, cardiovascular, anti-infective, liver care, orthopedics, anticancer, anti-parasitic, immunosuppressant, etc.;...
Where does 600267.SS trade?
Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS) trades on the Shanghai Stock Exchange.
What sector is 600267.SS in?
Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Zhejiang Hisun Pharmaceutical Co., Ltd.?
Weihong Xiao is the chief executive officer of Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS).
Where is Zhejiang Hisun Pharmaceutical Co., Ltd. headquartered?
Zhejiang Hisun Pharmaceutical Co., Ltd. is headquartered in China.
Does 600267.SS pay a dividend?
Yes — Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS) paid a trailing twelve-month dividend of CNY 0.21 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600267.SS go public?
Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS) completed its initial public offering in 2000.